MARKET HARBOROUGH MED.CTR
67 COVENTRY ROAD, MARKET HARBOROUGH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 69 | 70 | 98.6% | |
| HF 4 | 2011 | 62 | 69 | 89.9% | |
| HF 4 | 2012 | 56 | 62 | 90.3% | |
| HF 4 | 2013 | 48 | 53 | 90.6% | |
| HF004 | 2014 | 20 | 21 | 95.2% | |
| HF004 | 2015 | 17 | 18 | 94.4% | |
| HF004 | 2016 | 19 | 22 | 86.4% | |
| HF004 | 2017 | 18 | 22 | 81.8% | |
| HF004 | 2018 | 19 | 21 | 90.5% | |
| HF004 | 2019 | 26 | 31 | 83.9% | |
| HF004 | 2020 | 28 | 30 | 93.3% | |
| HF006 | 2021 | 40 | 44 | 90.9% | |
| HF006 | 2022 | 202 | 218 | 92.7% | |
| HF006 | 2023 | 201 | 207 | 97.1% |
